SCHEMBL22925047

SCHEMBL22925047

N=Cc1cccc2[nH]ccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.50
MAPK1 P28482 1/20 0.43
PIK3CD O00329 1/20 0.42
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40
TUBA3C P0DPH7 1/20 0.40
TUBA1B P68363 1/20 0.40
TUBA4A P68366 1/20 0.40
TUBB4B P68371 1/20 0.40
TUBB3 Q13509 1/20 0.40
TUBB2A Q13885 1/20 0.40
TUBB8 Q3ZCM7 1/20 0.40
TUBA3E Q6PEY2 1/20 0.40
TUBA1A Q71U36 1/20 0.40
TUBA1C Q9BQE3 1/20 0.40
TUBB6 Q9BUF5 1/20 0.40
TUBB2B Q9BVA1 1/20 0.40
TUBB1 Q9H4B7 1/20 0.40
RHEB Q15382 9/20 0.40
ADRB1 P08588 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5437029 0.79 AHR (0.50) AHRMAPK1PIK3CDTUBB4ATUBB
SCHEMBL97761 0.79 CYP2A6 (0.57) AHRMAPK1PIK3CDTUBB4ATUBB
SCHEMBL10923774 0.79 AHR (0.50) AHRMAPK1PIK3CDTUBB4ATUBB
SCHEMBL8051282 0.79 AHR (0.50) AHRMAPK1PIK3CDTUBB4ATUBB
SCHEMBL28168668 0.78 CYP2A6 (0.55) AHRMAPK1PIK3CDTUBB4ATUBB
SCHEMBL9605441 0.76 AHR (0.47) AHRMAPK1PIK3CDTUBB4ATUBB
SCHEMBL10547155 0.75 AHR (0.46) AHRMAPK1PIK3CDTUBB4ATUBB
SCHEMBL29175359 0.75 HPGD (0.61) AHRMAPK1PIK3CDTUBB4ATUBB
SCHEMBL27983052 0.75 HPGD (0.61) AHRMAPK1PIK3CDTUBB4ATUBB
SCHEMBL10720454 0.75 AHR (0.46) AHRMAPK1PIK3CDTUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021012264-A1 TRIAZOLE SULFONAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 东莞市东阳光农药研发有限公司 2021-01-28 WO disclosed